Novel Coronavirus (SARS-CoV-2/COVID-19)
Today, we continue to grapple not only with the COVID-19 pandemic, but also a dangerously polarized election, ongoing civil unrest in the face of untenable systemic racism … and now, 94 major wildfires that are devastating our West Coast neighbors, families and friends, as well as recent hurricanes…
The AHA requests that the Department of Health and Human Services revise certain FAQs that place problematic restrictions on the use of some CARES Act Provider Relief Fund dollars.
The Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response recently posted new and updated COVID-19 resources at its Technical Resources, Assistance Center, and Information Exchange.
The Food and Drug Administration approved dexmedetomidine hydrochloride in 0.9% sodium chloride injection for the sedation of initially intubated and mechanically ventilated patients in an intensive-care setting and of non-intubated patients prior to and/or during surgical and other procedures.
The National Institutes of Health awarded $12 million to non-profit research institution RTI International for outreach and engagement efforts in ethnic and racial minority communities that have been disproportionately affected by the COVID-19 pandemic.
A new Centers for Disease Control and Prevention study suggests that social distancing and other measures to stop the spread of SARS-CoV-2 could help reduce the impact of flu this fall and winter in the United States if widely practiced.
The AHA, along with numerous others, have rightly labeled this pandemic the greatest financial threat in history for hospitals and health systems as we continue to fight this pandemic at the same time that non-COVID patient visits remain down. This financial pressure has created a serious obstacle…
The Department of Health and Human Services today released its strategy for the public distribution of a COVID-19 vaccine.
The Food and Drug Administration released comparative performance data for 55 COVID-19 molecular diagnostic tests.
The Department of Health and Human Services released its strategy for the public distribution of a COVID-19 vaccine. HHS said that it developed the strategy in coordination with the Department of Defense and the Centers for Disease Control and Prevention.